Health
NewLimit Raises Funding for Clinical Trial
Longevity startup NewLimit secured $435 million to fund its first clinical trial of a liver medicine. The company plans to launch the trial soon.
Coverage timeline — 1 article
STAT News
Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.
2026-06-02 17:00 UTC